MSK1 activators belong to a specialized class of chemical compounds designed to modulate the activity of Mitogen- and Stress-Activated Protein Kinase 1 (MSK1). MSK1 is a serine/threonine kinase that is a critical component of intracellular signaling pathways regulating various cellular processes, including gene expression, cell proliferation, and stress responses. MSK1 is particularly known for its role as a downstream effector of the mitogen-activated protein kinase (MAPK) signaling pathway and its involvement in the regulation of transcription factors, such as CREB (cAMP response element-binding protein) and ATF1 (activating transcription factor 1). When activated, MSK1 phosphorylates these transcription factors, thereby modulating their transcriptional activity and influencing the expression of target genes involved in diverse cellular functions.
MSK1 activators are designed to interact with the MSK1 protein, modulating its kinase activity and impacting downstream signaling cascades. These compounds are instrumental in research aimed at understanding the molecular mechanisms of cellular responses to extracellular stimuli, stress, and various physiological processes. By manipulating MSK1 activity, scientists can gain valuable insights into the complex regulatory networks that govern gene expression, cell proliferation, and stress responses, shedding light on fundamental cellular biology. MSK1 activators play a crucial role in advancing our knowledge of intracellular signaling pathways, contributing to the broader field of molecular and cellular biology, and providing a deeper understanding of how cells respond to diverse environmental cues and stressors.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates MAPK pathways (JNK, p38), leading to the downstream activation of MSK1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor, can indirectly affect MSK1 activity through the p38 MAPK pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, alters ERK pathway activity, thereby influencing MSK1 activation. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Multi-targeted receptor tyrosine kinase inhibitor, can indirectly influence MSK1 through various pathways. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
MEK inhibitor, impacts ERK/MAPK signaling, potentially affecting MSK1 activation. | ||||||
LY2228820 | 862507-23-1 | sc-364525 | 5 mg | $191.00 | 1 | |
p38 MAPK inhibitor, indirectly modulates MSK1 activity. | ||||||
VX 745 | 209410-46-8 | sc-361401 sc-361401A | 10 mg 50 mg | $183.00 $842.00 | 4 | |
p38 MAPK inhibitor, affects MSK1 by modulating upstream signaling pathways. | ||||||
ERK Inhibitor II, FR180204 | 865362-74-9 | sc-203945 sc-203945A sc-203945B sc-203945C | 1 mg 5 mg 10 mg 50 mg | $110.00 $165.00 $239.00 $942.00 | 45 | |
ERK inhibitor, can influence MSK1 activity by altering ERK signaling. | ||||||
SCH772984 | 942183-80-4 | sc-473205 | 5 mg | $370.00 | 5 | |
ERK inhibitor, potentially affects MSK1 activity through modulation of the ERK pathway. | ||||||